TAIWAN · TWSE / TPEx
We Can
佑全 · 6929 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$21.801 month -1.1% · 1 year -27.2%
Directors and supervisors hold34,567,12476.7% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold34,402,47376.3% of shares issued
Revenue, 2026-09+5.2%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 劉志平 | Chairman | 164,651 | 164,651 | 0.37% | — | 2,000 |
| 生達化學製藥股份有限公司 | Vice chairman · Major shareholder (10%+) | 13,444,909 | 13,444,909 | 29.82% | — | — |
| 范滋庭 | Vice chairman (corporate representative) | — | 0 | — | — | — |
| 鄭振文 | Director | — | 0 | — | — | — |
| 優盛醫學科技股份有限公司 | Director · Major shareholder (10%+) | 20,957,564 | 20,957,564 | 46.48% | — | — |
| 文德蘭 | Director (corporate representative) · President | — | 54,000 | 0.12% | — | — |
| 張淑娟 | Director (corporate representative) · Other | — | 15,000 | 0.03% | — | — |
| 葉翠雯 | Director | — | 0 | — | — | — |
| 歐秀珠 | Independent director | — | 0 | — | — | — |
| 陳鴻運 | Independent director | — | 0 | — | — | — |
| 韓宗超 | Independent director | — | 0 | — | — | — |
| 張清為 | Vice president | — | 54,000 | 0.12% | — | — |
| 劉慧君 | Chief financial officer · Chief accountant | — | 0 | — | — | — |